Literature DB >> 6268928

Internal potassium balance and the control of the plasma potassium concentration.

R H Sterns, M Cox, P U Feig, I Singer.   

Abstract

The plasma potassium concentration is determined both by external potassium balance and by the distribution of potassium between extracellular and intracellular fluid compartments, i.e., "internal potassium balance." Whenever external potassium balance is altered, the resultant change in the plasma potassium concentration is strongly influenced by concomitant alterations in internal potassium balance. Several factors alter internal potassium balance independently of changes in external balance. Acid-base disturbances produce shifts of potassium into or out of cells, but attempts to quantify these effects are not likely to be clinically useful. Hypertonicity produces a shift of potassium out of cells. Several hormones (insulin, aldosterone, catecholamines, glucagon, and growth hormone) may have roles in internal potassium balance. Digitalis and succinylcholine, by producing efflux of potassium from cells, may cause hyperkalemia. Potassium is released from skeletal muscle during exercise, causing an increase in the plasma potassium concentration. The periodic paralyses are associated with well-defined transient alterations in internal potassium balance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268928     DOI: 10.1097/00005792-198109000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  34 in total

Review 1.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-19       Impact factor: 2.370

2.  Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1).

Authors:  Y Heianza; S Hara; Y Arase; K Saito; K Totsuka; H Tsuji; S Kodama; S D Hsieh; N Yamada; K Kosaka; H Sone
Journal:  Diabetologia       Date:  2011-01-07       Impact factor: 10.122

3.  Effect of prolonged physical exercise on intra-erythrocyte and plasma potassium.

Authors:  P Lijnen; P Hespel; R Fagard; M Goris; R Lysens; E Vanden Eynde; A Amery
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

4.  Diabetic state-induced modification of resting membrane potential and conductance in diaphragm muscle of alloxan and diabetic KK-CAy mice.

Authors:  M Kimura; I Kimura; T Nakamura; H Nojima
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 5.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Erythrocyte cations and Na+,K+-ATPase pump activity in athletes and sedentary subjects.

Authors:  P Hespel; P Lijnen; R Fiocchi; S Van Oppens; E Vanden Eynde; A Amery
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

7.  Hyperkalaemia during massive blood transfusion in paediatric craniofacial surgery.

Authors:  K A Brown; B Bissonnette; M MacDonald; A O Poon
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

8.  Intravenous KCl supplementation in pediatric cardiac surgical patients.

Authors:  D E Schaber; D L Uden; F M Stone; A Singh; H Katkov; F B Bessinger
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

9.  A physiologic-based approach to the treatment of a patient with hypokalemia.

Authors:  Abdo Asmar; Rajesh Mohandas; Charles S Wingo
Journal:  Am J Kidney Dis       Date:  2012-09       Impact factor: 8.860

10.  Changes in serum potassium mediate thiazide-induced diabetes.

Authors:  Tariq Shafi; Lawrence J Appel; Edgar R Miller; Michael J Klag; Rulan S Parekh
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.